A review of the pharmacokinetics and pharmacodynamics of remifentanil.

[1]  P. Sebel,et al.  Fentanyl or Alfentanil Decreases the Minimum Alveolar Anesthetic Concentration of Isoflurane in Surgical Patients , 1994, Anesthesia and analgesia.

[2]  B. Jamerson,et al.  Intracranial Pressure and Hemodynamic Effects of Remifentanil Versus Alfentanil in Patients Undergoing Supratentorial Craniotomy , 1996, Anesthesia and analgesia.

[3]  R. Miguel,et al.  A Multicenter Evaluation of Total Intravenous Anesthesia with Remifentanil and Propofol for Elective Inpatient Surgery , 1996, Anesthesia and analgesia.

[4]  Thomas W. Schnider,et al.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development , 1997 .

[5]  B. Jamerson,et al.  Initial clinical experience with remifentanil, a new opioid metabolized by esterases. , 1995 .

[6]  A. McEwan,et al.  MAC reduction of isoflurane by sufentanil. , 1994, British journal of anaesthesia.

[7]  P. Glass,et al.  Dose Comparison of Remifentanil and Alfentanil for Loss of Consciousness , 1997, Anesthesiology.

[8]  David J. Hermann,et al.  The Pharmacokinetics of the New Short‐acting Opioid Remifentanil (GI87084B) in Healthy Adult Male Volunteers , 1993, Anesthesiology.

[9]  A. McEwan,et al.  Isoflurane Minimum Alveolar Concentration Reduction by Fentanyl , 1993, Anesthesiology.

[10]  A. Fox,et al.  Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  M. K. James,et al.  Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. , 1997, The Journal of pharmacology and experimental therapeutics.

[12]  K T Muir,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver Disease , 1996, Anesthesiology.

[13]  D. Goodman,et al.  Plasma Concentration of Fentanyl, with 70% Nitrous Oxide, to Prevent Movement at Skin Incision , 1993, Anesthesiology.

[14]  M. K. James,et al.  Effects of Remifentanil, a New Short‐acting Opioid, on Cerebral Blood Flow, Brain Electrical Activity, and Intracranial Pressure in Dogs Anesthetized with Isoflurane and Nitrous Oxide , 1993, Anesthesiology.

[15]  M. K. James,et al.  Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. , 1991, The Journal of pharmacology and experimental therapeutics.

[16]  Juliana Barr,et al.  Remifentanil Versus Alfentanil: Comparative Pharmacokinetics and Pharmacodynamics in Healthy Adult Male Volunteers , 1996, Anesthesiology.

[17]  P. Glass,et al.  Measured context-sensitive half-times of remifentanil and alfentanil. , 1995 .

[18]  K T Muir,et al.  Pharmacokinetics of Remifentanil (GI87084B) and Its Major Metabolite (GI90291) in Patients Undergoing Elective Inpatient Surgery , 1993, Anesthesiology.

[19]  P. Glass,et al.  Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra‐Short‐Acting Opioid: Remifentanil (GI87084B) , 1993, Anesthesia and analgesia.

[20]  M. K. James,et al.  Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. , 1992, The Journal of pharmacology and experimental therapeutics.

[21]  Donald R. Stanski,et al.  Comparison of a Computer‐assisted Infusion Versus Intermittent Bolus Administration of Alfentanil as a Supplement to Nitrous Oxide for Lower Abdominal Surgery , 1988, Anesthesiology.

[22]  P. Sebel,et al.  Histamine Concentrations and Hemodynamic Responses After Remifentamil , 1995, Anesthesia and analgesia.